Search Results
Clinical outcomes associated with metformin, DPP4 inhibitor or insulin use in COVID patients w T2D
DPP4 inhibitors Clinical Cases & Updates
Covid - 19 & Cardio-metabolic disease & Multi factorial risk management of diabetic Patients
UCC presents Professor Neil R Poulter CV Outcome Trials in Type 2 Diabetes: A Review
0138: SGLT2 & DPP4 Inhibitors - (1) CV & Renal Outcomes ; (2) Glycemic Control
Pharmacology Series: Updates in Guidelines for Chronic Conditions: “Diabetes”
DPP4 inhibitors - Prof. Rayaz Malik - AASD
Management of Patients with Type 2 Diabetes
KDIGO Diabetes in CKD Guideline Webinar: Looking at the Latest Evidence and Beyond
Management of Type-2 DM: The Advantage of Using DPP4 Inhibitor in daily Practice
10 Years of Simplicity in Managing Type 2 Diabetes part 1 03/09/2021
Dialogue Webinar on Handling T2DM Patients During COVID-19 & Mngmt of Thyroid Associated Orbitopathy
